logo

For the Inventor, By the Inventor

Rome, Italy

Valerio Caciagli

This inventor holds 6 USPTO granted patents. Top assignees: Sclavo Spa, Enichem Elastomeri S.p.a., Menarini Ricerche S.p.a.. Active years: 1977-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valerio Caciagli. Retrieved from https://idiyas.com/inventor/valerio-caciagli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 83.3

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal2 out of 44 
 
Sclavo Spa
 patents
silverMedal1 out of 16 
 
Enichem Elastomeri S.p.a.
 patents
bronzeMedal1 out of 8 
 
Menarini Ricerche S.p.a.
 patents
4. 1 out of 1 
 
Sclano S.p.a.
 patent
5. 1 out of 336 
 
Snamprogetti
 patents

Years Active: 1977-2007

Loading Chart...
6 patents (USPTO):Explore Patents
1. 7273856 - Linear basic compounds having NK-2 antagonist activity and formulations thereof (2007-09-25),
2. 5130447 - Process for the synthesis of N.sup..alpha. (1992-07-14),
3. 5112996 - Method for alkylating guanidino groups (1992-05-12),
4. 5079375 - Process for the synthesis of N.sup..alpha. (1992-01-07),
5. 4810779 - Decapeptides having hypotensive action and process for their preparation (1989-03-07),
6. 4001333 - Process for the preparation of dioldiones (1977-01-04),

Title: The Innovative Contributions of Valerio Caciagli

Introduction

Valerio Caciagli is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of six patents to his name, Caciagli's work has had a meaningful impact on medical science.

Latest Patents

Caciagli's latest patents include "Linear basic compounds having NK-2 antagonist activity and formulations thereof." This patent describes compounds that are useful as antagonists of tachykinins, specifically neurokinin A. Additionally, he has developed a "Process for the synthesis of N.sup..alpha. -trityl-N.sup.G -trityl arginine," which improves the synthesis method for a specific arginine derivative.

Career Highlights

Throughout his career, Valerio Caciagli has worked with prominent companies in the pharmaceutical industry, including Sclavo Spa and Menarini Ricerche S.p.a. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects.

Collaborations

Caciagli has collaborated with esteemed colleagues such as Antonio S Verdini and Alessandro Sisto. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Valerio Caciagli's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…